Hypertension Trial, Recruiting NCT06555952 Sponsor: Clinical Nutrition Research Center, Illinois Institute of Technology Condition: Hypertension
Back to Hypertension

Hypertension Trial, Recruiting

NCT06555952
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People between 40 and 60 years of age
  • People with a body mass index (a measure of body weight relative to height) below 30
  • People with a systolic blood pressure (the top number) between 120 and 140, and a diastolic blood pressure (the bottom number) below 90, measured at the screening visit
  • People whose fasting blood sugar level falls between 100–125 mg/dL, or whose HbA1c (a measure of average blood sugar over time) is between 5.7% and 6.4%
  • People who are not currently taking medications that could affect blood pressure or blood sugar levels
  • People who are able to give informed consent to participate
  • People who are able to follow the study procedures, including dietary restrictions, eating the study foods, keeping a food diary, completing questionnaires, providing samples, and attending study visits
  • People who are able to maintain their usual level of physical activity throughout the study
  • People who are able to avoid alcohol and intense physical activity for 24 hours before and during each study visit

Who may not be able to join:

  • People with a known or suspected intolerance, allergy, or sensitivity to any of the study foods or interventions
  • People who have diabetes, or who have a documented liver, kidney, heart, digestive, metabolic, or respiratory condition
  • People with a physical or mental health condition, or who have had major surgery, that might affect their ability to complete the study or that a doctor believes could affect the study results
  • Women who are pregnant or planning to become pregnant during the study
  • Women who are currently breastfeeding
  • People taking medications or dietary supplements that may affect the study results, including anti-inflammatory medicines such as ibuprofen, naproxen, or aspirin
  • People who have experienced a major injury or had surgery within the past 2 months (or longer, depending on the situation, as determined by the study investigator)
  • People who have taken antibiotics within the past 2 months
  • People who have had a colonoscopy within the past 3 months
  • People with a history of an eating disorder (such as anorexia nervosa, bulimia nervosa, or binge eating) that has been diagnosed by a health professional
  • People with a history of alcohol or drug misuse within the past 2 years
  • People who drink more than 4 cups of coffee or tea per day
  • People who have donated blood within the past 3 months
  • People who exercise excessively on a regular basis, or who are competitive athletes
  • People whose weight has changed by more than 5 kg (11 lbs) in either direction over the past 2 months
  • Women who are taking a hormonal contraceptive at an unstable dose or brand, or who have been on a stable dose and brand for less than 6 months
  • People who work overnight or non-standard hours (such as night shifts)
  • People who follow a vegan diet or any other highly restrictive eating pattern

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Britt Burton-Freeman, 708-563-8276

Phone: 708-563-8178

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Clinical Nutrition Research Center, Illinois Institute of Technology
Registry
ClinicalTrials.gov
Start date
8 August 2024
Est. completion
22 July 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Difference in change of systolic blood pressure; Difference in change of diastolic blood pressure

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov